XBiotech Inc.
XBIT
$8.61
-$0.72-7.72%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.02M | 202.19M | 204.77M | 212.66M | 217.48M |
| Total Receivables | 935.00K | 1.33M | 3.79M | 2.92M | 1.76M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 760.00K | 879.00K | 947.00K | 703.00K | 601.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 201.72M | 204.40M | 209.51M | 216.28M | 219.84M |
|
|
|||||
| Total Current Assets | 201.72M | 204.40M | 209.51M | 216.28M | 219.84M |
| Net Property, Plant & Equipment | 24.90M | 25.20M | 25.62M | 25.84M | 26.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 226.62M | 229.60M | 235.14M | 242.12M | 246.10M |
|
|
|||||
| Total Accounts Payable | 2.52M | 1.47M | 1.82M | 1.36M | 2.41M |
| Total Accrued Expenses | 3.50M | 3.67M | 2.63M | 2.21M | 1.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 83.00K | 159.00K | -- | 55.00K | 55.00K |
| Total Other Current Liabilities | 83.00K | 159.00K | -- | 55.00K | 55.00K |
| Total Current Liabilities | 6.10M | 5.29M | 4.45M | 3.62M | 4.07M |
|
|
|||||
| Total Current Liabilities | 6.10M | 5.29M | 4.45M | 3.62M | 4.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.67M | 1.65M | 1.62M | 1.60M | 1.64M |
| Total Liabilities | 7.77M | 6.94M | 6.07M | 5.22M | 5.70M |
|
|
|||||
| Common Stock & APIC | 271.15M | 269.89M | 268.93M | 268.03M | 267.33M |
| Retained Earnings | -52.31M | -47.67M | -40.31M | -31.57M | -27.75M |
| Treasury Stock & Other | -- | 440.00K | 440.00K | 440.00K | 826.00K |
| Total Common Equity | 218.85M | 222.66M | 229.06M | 236.91M | 240.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 218.85M | 222.66M | 229.06M | 236.91M | 240.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 218.85M | 222.66M | 229.06M | 236.91M | 240.40M |
|
|
|||||
